Going global with its mix
Anteo Diagnostics Ltd, (ADO.AX) produces a proprietary, metal-ion based ‘glue’ called Mix&Go to couple antibodies used in diagnostic tests to diagnostic devices. The sophisticated chemistry is claimed to improve the speed and sensitivity of tests. Anteo has an important collaborative agreement with BBI Solutions to investigate the potential benefits of Mix&Go in point-of-care diagnostics. A successful BBI project during 2014 could lead to a major commercial agreement. Anteo raised a further A$5.5m in December 2013, issuing 44m shares at 12.5c.
Mix&Go: Surface-coating technology
Mix&Go is a proprietary family of metal co-ordination complexes. Through its Bio- Layer subsidiary, Anteo has optimised a chromium formulation to bind the tails of antibodies irreversibly to synthetic surfaces, including nanoparticles. This can improve the test’s sensitivity. The technology is covered by granted patents in the US, Europe, Japan and Australia.
Patents and funding to extend Mix&Go scope
The advantages of using Mix&Go purportedly include simplicity and faster assays with greater sensitivity and improved dynamic range and reduced production costs. Two new patents filed in August 2013 could allow expansion into bioseparations, drug screening, drug delivery and non-healthcare applications. The new funds will support product development and commercialisation and new business creation.
To Read the Entire Report Please Click on the pdf File Below